Latest issue of Clinical laboratory
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
IL-6 biomarker breakthrough for early sepsis detection
Sepsis, /in E-News, Molecular Diagnostics /by panglobalNew research identifies interleukin-6 as a superior diagnostic biomarker for sepsis in high-risk populations including neonates, children, and pregnant women.
Pfizer halts development of oral GLP-1 agonist danuglipron
, /in E-News /by panglobalSafety concerns prompt Pfizer to terminate development of once-daily oral GLP-1 receptor agonist for weight management, despite promising pharmacokinetic data from recent dose-optimisation studies.
Basel-based equity-free DayOne Accelerator opens for healthtech startups
, /in E-News /by panglobalBasel’s equity-free pharma-focused accelerator programme returns to bridge the gap between healthtech innovations and pharmaceutical R&D needs.
Bruker expands infectious disease diagnostics portfolio at ESCMID 2025
, /in Product News /by panglobalBruker Corporation has announced significant expansions to its infectious disease testing solutions at the ESCMID Global conference in Vienna, including a broader assay menu for its BeGenius® molecular diagnostics system and improvements to its microbial identification platforms.
Beckman Coulter introduces next-gen basophil activation test for allergy research
, /in E-News /by panglobalBeckman Coulter Life Sciences has launched a ground-breaking Next-Generation Basophil Activation Test (BAT) that could transform food allergy research by eliminating the need for potentially dangerous allergen exposure.
Bio-Rad secures IVDR certification for molecular quality controls portfolio
, /in E-News /by panglobalBio-Rad Laboratories has achieved a significant regulatory milestone with EU Quality Management Systems certification under the In Vitro Diagnostic Regulation (IVDR), enabling CE marking for 40 infectious disease molecular quality control products from their Exact Diagnostics brand.
Revvity expands genomic sequencing services with Genomics England in landmark newborn screening programme
, /in E-News /by panglobalRevvity, Inc. has significantly expanded its collaboration with Genomics England to provide comprehensive genomic screening services for newborns in England. The new agreement builds upon an existing partnership by adding DNA sequencing services to Revvity’s current DNA extraction capabilities.
4basebio secures MHRA GMP certification for synthetic DNA production
, /in E-News /by panglobalCambridge-based 4basebio has received Good Manufacturing Practice certification from the UK’s Medicines and Healthcare products Regulatory Agency, enabling the company to supply GMP-grade synthetic DNA for clinical applications in cell and gene therapy development.
Cystic Fibrosis Foundation invests in Owlstone to develop breath test for Pseudomonas detection
, /in E-News /by panglobalThe Cystic Fibrosis Foundation has committed up to US$2.3 million (about £1.7 million) in equity investment to Owlstone Medical for the development of a breath test to detect Pseudomonas aeruginosa (PA) infections in people with cystic fibrosis (CF). The Cambridge-based company announced the investment on March 25, 2025, marking a significant step forward in respiratory […]
Simple blood test measures type 1 diabetes autoimmunity in children
, /in E-News /by panglobalInnovative assay requires minimal blood sample while providing high accuracy